Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.

John Boyages,Frank A Vicini,Behnaz Azimi Manavi,Richelle L Gaw,Louise A Koelmeyer,Sheila H Ridner,Chirag Shah

JCO oncology practice（2023）

引用 0|浏览10

暂无评分

摘要

The extent of axillary treatment is a significant risk factor for cBCRL. Increasing BMI, rurality, SCF radiation, and taxane chemotherapy also increase risk. These results have implications for a proposed risk-based lymphedema screening, early intervention, and treatment program.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要